Recent news on Mycamine

Mycamine™ Equivalent to Ambisome® with Less Side Effects for ...  -  May 9, 2007
Cancer Consultants (press release),An international randomized trial has demonstrated that Mycamine (micafungin) is equivalent to Ambisome (liposomal amphotericin B) for the treatment of

Astellas Drug Is Less Risky Than Older Antifungal, Lancet Says  -  Apr 25, 2007
BloombergResearchers found micafungin, sold as Mycamine in the US, helped patients with systematic candidosis, an infection that causes lesions on internal organs,

Astellas and Daiichi Sankyo figures fail to dazzle  -  May 16, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder leapt 144.3% to 36.2 billion yen while the antifungal agent Funguard/Mycamine (micafungin) had sales of 16.5

Astellas Drug Is Less Risky Than Older Antifungal, Lancet Says  -  26 Apr 2007
BloombergResearchers found micafungin, sold as Mycamine in the US, helped patients with systematic candidosis, an infection that causes lesions on internal organs,

Micafungin Effective for Serious Candida Infections  -  26 Apr 2007
MedPage Today,Explain that this study concludes that micafungin (Mycamine) is as effective as liposomal amphotericin B (Ambisome) in treating these serious infections,

Mitsubishi/Tanabe merger may be first of many in Japan  -  Feb 5, 2007
Pharma Times (subscription),North American sales were up 1.6% to 128.5 thanks to Prograf, Vesicare, the antifungal agent Mycamine (micafungin) and Amevive (alefacept) for psoriasis,

Astellas Pharma US, Inc. Announces Availability of MYCAMINE(R ...  -  Jan 15, 2007
Drug Newswire (press release),The addition of this vial size will increase the convenience of use when administering MYCAMINE while decreasing waste in the hospital setting.

100mg Vial  -  Jan 16, 2007
Pharmaceutical Processing,Astellas Pharma US, Inc. has announced the availability of their antifungal agent MYCAMINE® (micafungin sodium) for injection in a 100mg vial format.

Astellas Pharma US, Inc. Announces Availability Of MYCAMINE(R ...  -  Jan 13, 2007
Medical News Today (press release),Astellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE(R) (micafungin sodium) for injection in a 100mg vial format.

Astellas launches bigger vial of Mycamine  -  Jan 12, 2007
United Press International12 (UPI) -- US firm Astellas Pharma said Friday its anti-fungal agent Mycamine is now available in a larger, 100 mg vial. Since Mycamine was approved in

Astellas Pharma US, Inc. Submits Supplemental New Drug Application ...  -  Dec 26, 2006
PR Newswire (press release),In 2005, MYCAMINE received approval by the FDA for the treatment of patients with esophageal candidiasis and prophylaxis of Candida infection in patients

Astellas terminates development of heart failure drug in US  -  Jan 12, 2007
Pharma Times (subscription),...seeking approval for the use of its antifungal agent Mycamine (micafungin) for injection in the treatment of candidemia and other candida infections.

(PRN) - Nav-a-Trip Points GPS Renters in the Right Direction ... [+]  -  Jan 12, 2007
Bolsamania.com,...(PRN) - Astellas Pharma US, Inc. Announces Availability of MYCAMINE(R) 100mg Vial ... [+]. (PRN) - Monogram Biosciences Prices Private Placement of

Sección internacional  -  Dec 26, 2006
Bolsamania.com,...(PRN) - Astellas Pharma US, Inc. Submits Supplemental New Drug Application For Antifungal Product MYCAMINE(R) ... [+]. (PRN) - American Suzuki Shows Full

Research and Markets: Astellas Pharma Aims To Secure a Top Share ...  -  Dec 20, 2006
PharmaLive.com (press release),Astellas' new products, Funguard/Mycamine and Vesicare made a significant contribution to sales in fiscal 2005. Funguard has a market share of 50 per cent

Astellas Pharma US, Inc. Submits Supplemental New Drug Application ...  -  26 Dec 2006
PR Newswire (press release),In 2005, MYCAMINE received approval by the FDA for the treatment of patients with esophageal candidiasis and prophylaxis of Candida infection in patients

Sección internacional  -  26 Dec 2006
Bolsamania.com,...(PRN) - Astellas Pharma US, Inc. Submits Supplemental New Drug Application For Antifungal Product MYCAMINE(R) ... [+]. (PRN) - American Suzuki Shows Full

Research and Markets: Astellas Pharma Aims To Secure a Top Share ...  -  Dec 20, 2006
PharmaLive.com (press release),Astellas' new products, Funguard/Mycamine and Vesicare made a significant contribution to sales in fiscal 2005. Funguard has a market share of 50 per cent

Income From 2 Sources  Jul 15, 2006
And on March 28, 2003, Walsh accompanied Fujisawa executives when they met privately with FDA staff to discuss the company's latest antifungal, Mycamine. ... -Los Angeles Times



Astellas Pharma Obtains Approval for Funguard and Vesicare  Apr 21, 2006
Funguard for Infusion (micafungin sodium), which was initially launched in December 2002, is available in the US under the trade name of Mycamine and currently ... - Japan Corporate News

Astellas Pharma Files Application For Candin Antifungal Agent ...  Apr 17, 2006
Currently, micafungin is available in Japan and the US, under the trade names Funguard for Infusion and Mycamine, respectively. ... - Medical News Today

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional